Literature DB >> 28457877

Assessing cutaneous microvascular function with iontophoresis: Avoiding non-specific vasodilation.

Jordan Loader1, Matthieu Roustit2, Frances Taylor3, Richard J MacIsaac4, Simon Stewart5, Christian Lorenzen6, Guillaume Walther7.   

Abstract

AIM: Iontophoresis of vasoactive agents is commonly used to assess cutaneous microvascular reactivity. However, it is known that iontophoresis can be limited by confounding non-specific vasodilatory effects. Despite this, there is still no standardization of protocols or data expression. Therefore, this study evaluated commonly used protocols of iontophoresis by assessing each for evidence of non-specific vasodilatory effects and examined the reproducibility of those protocols that are free of non-specific responses.
METHODS: Twelve healthy participants were administered doses of acetylcholine (ACh) 1-2% and sodium nitroprusside (SNP) 1%, diluted in sodium chloride 0.9% or deionized water, and insulin 100U/mL in a sterile diluent using iontophoresis coupled with laser speckle contrast imaging (LSCI). Increases in blood flux at a control electrode, containing the diluent only, indicated a non-specific response. Reproducibility of iontophoresis protocols that were free of non-specific vasodilatory effects were subsequently compared to that of post-occlusive reactive hyperemia (PORH), used as a standard, in 20 healthy participants.
RESULTS: Iontophoresis of ACh or SNP in sodium choloride (0.02mA for 200 and 400s, respectively) and ACh in deionized water (0.1mA for 30s) mediated the least non-specific vasodilatory effects. Microvascular responses to insulin were mediated mainly by non-specific effects. Compared to PORH, the intraday and interday reproducibility for iontophoresis of ACh and SNP (0.02mA for 200 and 400s, respectively) with LSCI was weaker, but still deemed good to excellent when data was expressed, in perfusion units or cutaneous vascular conductance, as the absolute peak blood flux response to the vascular reactivity test or as the change in blood flux between peak and baseline values.
CONCLUSION: This study provides updated recommendations for assessing cutaneous microvascular function with iontophoresis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Iontophoresis; Laser speckle contrast imaging; Microcirculation; Post-occlusive reactive hyperemia

Mesh:

Substances:

Year:  2017        PMID: 28457877     DOI: 10.1016/j.mvr.2017.04.006

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  5 in total

1.  Endothelial function may be enhanced in the cutaneous microcirculation after a single air dive.

Authors:  François Guerrero; Kate Lambrechts; Qiong Wang; Aleksandra Mazur; Michael Théron; Alessandro Marroni
Journal:  Diving Hyperb Med       Date:  2020-09-30       Impact factor: 0.887

2.  Early Endothelial Dysfunction in Type 1 Diabetes Is Accompanied by an Impairment of Vascular Smooth Muscle Function: A Meta-Analysis.

Authors:  Elodie Lespagnol; Luc Dauchet; Mehdi Pawlak-Chaouch; Costantino Balestra; Serge Berthoin; Martin Feelisch; Matthieu Roustit; Julien Boissière; Pierre Fontaine; Elsa Heyman
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-17       Impact factor: 5.555

3.  Reproducibility and normalization of reactive hyperemia using laser speckle contrast imaging.

Authors:  Behnia Rezazadeh Shirazi; Rudy J Valentine; James A Lang
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

4.  Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapy.

Authors:  Heather R Banister; Stephen T Hammond; Shannon K Parr; Shelbi L Sutterfield; Vanessa-Rose G Turpin; Scott Treinen; Martin J Bell; Carl J Ade
Journal:  Cardiooncology       Date:  2021-05-13

5.  Delayed Cutaneous Microvascular Responses With Non-consecutive 3 Days of Remote Ischemic Preconditioning.

Authors:  Jahyun Kim; Warren D Franke; James A Lang
Journal:  Front Physiol       Date:  2022-03-14       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.